Molecular diagnostics are seen as being a major breakthrough in medical science. While the technology itself has broad applications to such areas as agricultural bioterrorism and environmental science, medical and medical research applications have provided the primary focus. As a result, great things have been predicted for the development and use of new therapeutics based on molecular testing approaches.

The primary molecular diagnostics approaches are based on two major database sciences (genomics and proteomics) and their relationship to disease and metabolic processes (functional genomics and functional proteomics). The genome or proteome that forms the basis for these tests is very often of human origins, but may also be from a pathogen. As a result, the breadth of application for molecular diagnostic is virtually unlimited. With all this opportunity, however, progress has been slow in the development, introduction and commercialization of molecular diagnostics. This has been related to the difficulty and expense of performing such assays, and the utility of the test procedures in the absence of substantive therapeutic options based on the additional data provided by these assays.

This study looks at the basis for molecular diagnostics in the fields of genomics and proteomics; the technologies that are used to apply genomic and proteomic data to the diagnosis of disease; the diseases and conditions that are primary and secondary targets for this technology; the economics of molecular diagnostic testing; and its potential impacts on medical practice and the diagnostics markets over the next ten years. Number of tests, market potential, and estimated cost per test is provided for each test for each of the 10 years.

Related Reports:

IVD Market Research Supplement : Testing Services Markets, SNP Analysis, DNA Sequencing, Retail Clinics, Companion Diagnostics
Aug 1, 2008 - KLI1836320 - $8,995.00

Companion Diagnostics Markets (A Realistic Assessment of the Opportunities, Challenges, Key Players and Important Trends in 'Theranostics' and Personalized Medicine)
Jun 1, 2008 - KLI1646599 - $2,995.00

Molecular Diagnostics in China
Feb 1, 2008 - KLID1646608 - $6,000.00

Early Toxicology: Markets and Approaches
Jun 1, 2007 - KLI1300095 - $3,495.00

Molecular Diagnostics: Major World Markets
Feb 1, 2007 - KLI1365888 - $3,300.00

Clinical Diagnostics in India: Market Sector Analyses and Participant Directory
Dec 1, 2006 - KLI1362420 - $4,995.00

Molecular Imaging Agents and Systems: A Market Briefing
Jun 1, 2005 - KLI1052646 - $995.00

Cell-Based Diagnostics: Technology, Applications, and Markets
Jan 1, 2005 - KLI975813 - $3,500.00

Molecular Diagnostics for Infectious Disease Testing: Testing volume, cost per test, and market potential
Oct 1, 2004 - KLI1037841 - $995.00

Molecular Diagnostics for Pharmacogenetic Testing: Testing volume, cost per test, and market potential
Oct 1, 2004 - KLI1037838 - $995.00